Diversified Trust’s Ascendis Pharma A/S ASND Stock Holding History

Diversified Trust’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.93M	Sell	25,991 -11,170	-30%	-$2.61M	0.11%	103
2026 Q1	$8.5M	Sell	37,161 -5,090	-12%	-$1.14M	0.16%	70
2025 Q4	$9.01M	Sell	42,251 -3,430	-8%	-$708K	0.17%	67
2025 Q3	$9.08M	Buy	45,681 +263	+0.6%	+$49.1K	0.18%	70
2025 Q2	$7.84M	Sell	45,418 -1,130	-2%	-$184K	0.17%	72
2025 Q1	$7.25M	Buy	46,548 +1,510	+3%	+$216K	0.18%	70
2024 Q4	$6.2M	Buy	45,038 +3,114	+7%	+$409K	0.15%	79
2024 Q3	$6.26M	Buy	+41,924	New	+$5.66M	0.16%	79

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Diversified Trust's ASND Position: Q2 2026 in Review

Diversified Trust reduced its Ascendis Pharma A/S (ASND) stake by 30% in Q2 2026, selling an estimated $2.61M and leaving 25,991 shares worth $6.93M. The position accounts for 0.11% of the portfolio, ranked #103.

Diversified Trust first reported a position in ASND in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.08M in Q3 2025. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Diversified Trust held 25,991 shares of Ascendis Pharma A/S worth $6.93M as of Q2 2026.
Diversified Trust sold 11,170 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.61M.
Ascendis Pharma A/S made up 0.11% of Diversified Trust's portfolio in Q2 2026, its #103 holding.
Diversified Trust first reported a position in Ascendis Pharma A/S in Q3 2024 and has held it in 8 quarters since.
Diversified Trust's Ascendis Pharma A/S position peaked at $9.08M in Q3 2025.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.